These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8715799)
41. Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes. Roessler E; Herrera S; Espinoza M; Ayala A; Reynolds E; González F; Espinoza O; Undurraga A; Muñoz R; Arcos O; Galaz G Transplant Proc; 1998 Aug; 30(5):1756-7. PubMed ID: 9723268 [No Abstract] [Full Text] [Related]
42. Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators. Pinson CW; Beauregard-Zollinger L Transplant Proc; 1996 Aug; 28(4):2234-6. PubMed ID: 8769209 [No Abstract] [Full Text] [Related]
43. Measurement of lymphocyte cyclosporine levels in transplant patients. Masri MA; Barbari A; Stephan A; Rizk S; Kilany H; Kamel G Transplant Proc; 1998 Nov; 30(7):3561-2. PubMed ID: 9838559 [No Abstract] [Full Text] [Related]
44. Optimization of cyclosporine therapy in kidney transplantation. Remuzzi G; Perico N; Gaspari F Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238 [No Abstract] [Full Text] [Related]
46. Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. First MR; Weiskittel P; Burton ML; Shah MB; Dreyer D; Fleck P; Bey C; Peddi VR; Canafax DM; Schroeder TJ Transplant Proc; 1999; 31(1-2):324-5. PubMed ID: 10083127 [No Abstract] [Full Text] [Related]
47. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method. First MR; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder TJ Transplant Proc; 1998 Aug; 30(5):1701-5. PubMed ID: 9723249 [No Abstract] [Full Text] [Related]
48. Time-dependent difference of the 12-hour trough levels of cyclosporine in renal transplant recipients with sandimmune capsule. To H; Haba T; Uchida K; Fujimura A; Kobayashi E Transplant Proc; 2000 Feb; 32(1):221-2. PubMed ID: 10701028 [No Abstract] [Full Text] [Related]
49. Lessons from the Neoral Global Database. Helderman JH Transplant Proc; 1998 Aug; 30(5):1721-2. PubMed ID: 9723255 [No Abstract] [Full Text] [Related]
50. Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients. Kizilisik AT; al-Sebayel M; Ramirez CB Transplant Proc; 1998 Nov; 30(7):3537-8. PubMed ID: 9838549 [No Abstract] [Full Text] [Related]
52. Cyclosporine level: which single-point estimation of drug level is the best? Sharma R; Kumar J; Ahmed M; Gupta A; Gulati S; Sharma AP; Bhandari M Transplant Proc; 2001; 33(7-8):3124-5. PubMed ID: 11750343 [No Abstract] [Full Text] [Related]
53. Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients. Jirasiritham S; Mavichak V; Danviriyasup K; Jirasiritham S Transplant Proc; 2003 Feb; 35(1):236-7. PubMed ID: 12591379 [No Abstract] [Full Text] [Related]